Abstract
ADVERTISEMENT RETURN TO ISSUEEditorialNEXTIntroduction: Use of Radioactive Compounds in Drug Discovery and DevelopmentF. Peter Guengerich*View Author Information Department of Biochemistry and Center in Molecular Toxicology, Vanderbilt University School of Medicine, 638B Robinson Research Building, 2200 Pierce Avenue, Nashville, Tennessee 37232-0146, United States*Tel: 615-322-2261. Fax: 615-322-4349. E-mail: [email protected]Cite this: Chem. Res. Toxicol. 2012, 25, 3, 511–512Publication Date (Web):February 10, 2012Publication History Published online10 February 2012Published inissue 19 March 2012https://doi.org/10.1021/tx3000522Copyright © 2012 American Chemical SocietyRIGHTS & PERMISSIONSArticle Views1656Altmetric-Citations8LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit PDF (126 KB) Get e-AlertsSUBJECTS:Materials,Metabolism,Pharmaceuticals,Safety,Testing and assessment Get e-Alerts
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.